News releases from the National Institutes of Health (NIH)
Updated: 1 hour 42 min ago
NIH-supported study sheds light on the neural mechanisms underlying remission of depression.
Small-scale, NIH-led clinical study offers early hope for developing a treatment.
EBV is herpesvirus that causes infectious mononucleosis and is associated with certain cancers.
Previous studies have linked exposure to common air pollutants in pregnancy to low birthweight, preterm birth and stillbirth.
An NIH-funded review examined billing data from over 500,000 healthcare visits.
Experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines.
Cells use RNA to communicate; researchers may be able to translate this information into clinical applications.
Small NIH clinical trial conducted in partnership with AstraZeneca.
Health, substance use professionals must work together to thwart public health crisis.
Investigational vaccine designed to provide broad, durable protection from flu.
NIH experts review puzzling muscle paralysis condition in children.
Colchicine may potentially reduce complications accompanying metabolic syndrome.
Study sheds light on one way tumors may continue to grow despite the presence of cancer-killing immune cells.
Microglia may benefit, not damage, photoreceptors.
Group to help enhance inclusion of pregnant women and nursing mothers in clinical research.
NIH-funded study is an early step in effort to maintain fertility of childhood cancer patients.
Early stage trial opens at Clinical Center.
People taking the mineral for other medical reasons should stay the course.
Technique could aid early detection and treatment of certain eye diseases.
Bench-to-bedside: NIMH research leads to brexanolone, first-ever drug specifically for postpartum depression
Approximately 1 in 9 women in the United States experiences symptoms.